How much is Icosavax worth in 2026?

Icosavax has a current valuation of N/A based on their Early Stage VC (Series B) round and secondary market data.

How much funding has Icosavax raised?

Icosavax has raised N/A in total funding across 1 funding rounds.

Icosavax

Drug Discovery

Icosavax valuation and funding history | Last updated: April 7, 2021 | 1 funding rounds

Current Valuation

N/A

As of April 7, 2021

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series B)

$99.7M

Last Funding

Apr 2021

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
April 7, 2021	Early Stage VC (Series B)	$99.7M	N/A	-

Valuation Analysis

Current Valuation Metrics

Icosavax is currently valued at N/A as of April 7, 2021.

Track Icosavax Valuation Updates

Get notified when Icosavax raises new funding or valuation changes

Explore More Data

Detailed analysis for Icosavax

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Icosavax's valuation history, funding rounds, and growth metrics.

No credit card required

What is Icosavax Worth in 2026?

Icosavax is a leading private company in the Drug Discovery sector. Track Icosavax's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Icosavax Valuation is Determined

Private company valuations like Icosavax's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.